(July 18, 2024, 9:57 AM EDT) -- KANSAS CITY, Kan. — A Kansas federal judge has signed off on final approval to a settlement agreement in which Pfizer Inc. agreed to pay $50 million to settle claims that it conspired with others in an attempt to delay entry of generic competitors for the EpiPen XE
"EpiPen" epinephrine autoinjector (EAI) into the market....